Innovent Biologics
Get verified emails for Innovent Biologics employees
About Innovent Biologics
|
|
|
501-1,000 employees
View all Innovent Biologics employees
|
|
Pharmaceuticals
|
|
168 Dongping Street, Suzhou Industrial Park,Jiangsu 215123, China, Suzhou, Jiangsu 215123, CN
|
|
Established in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for the treatment of major diseases such as cancer. On 31 October, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK.
Since its inception, Innovent has developed a fully-integrated multi-functional platform which includes R&D, CMC (Chemistry, Manufacturing, and Controls), clinical development and commercialization capabilities. Leveraging the platform, the company has built a robust pipeline of 23 valuable assets in the fields of cancer, metabolic, autoimmune diseases and other major therapeutic areas, with 4 products, TYVYT® (sintilimab injection), BYVASDA® (bevacizumab injection), SULINNO® (adalimumab injection), HALPRYZA® (rituximab injection) officially approved for marketing in China, 5 assets in Phase III or pivotal clinical trials, and additional 14 molecules in to clinical trials. TYVYT® was included in the National Reimbursement Drug List (NRDL) in 2019 as the only PD-1 in that year and was also the first PD-1 inhibitor included in NRDL historically.
Innovent has built a biopharmaceutical production facility that operates under global standards. The design and operation of the clinical and commercial facilities are in compliance with the cGMP standards of NMPA, FDA and EMA. The existing production lines have already passed GMP audits by an international pharmaceutical company. Innovent has built an international team of advanced talents in high-end biological drug development and commercialization, including many overseas experts. The company has also entered into strategic cooperation with Eli Lilly, Adimab, Incyte, Hanmi and other international pharmaceutical companies.
|
Innovent Biologics Alternatives
Frequently Asked Questions about Innovent Biologics
Mengjie Jiang is the CEO of Innovent Biologics.
The decision makers in Innovent Biologics are Blake Salisbury, Cong Yao, Irene Lin, etc. Click to Find Innovent Biologics decision makers emails.
Innovent Biologics specializes in the development and commercialization of innovative biologics, including monoclonal antibodies, biosimilars, and other therapeutic proteins. Their services encompass the entire drug development process, from preclinical research and clinical trials to regulatory submissions and post-marketing support.
Innovent Biologics primarily serves the biopharmaceutical industry, focusing on the development of biologics for oncology, autoimmune diseases, and other therapeutic areas. They collaborate with pharmaceutical companies, research institutions, and healthcare organizations to advance innovative treatments.
To partner with Innovent Biologics, interested parties can reach out through their official website or contact their business development team directly. The partnership process typically involves initial discussions to understand project needs, followed by a detailed evaluation and agreement on collaboration terms.
Innovent Biologics adheres to strict quality control and regulatory standards throughout the drug development process. They implement Good Manufacturing Practices (GMP) and conduct rigorous testing and validation at each stage of production to ensure the safety, efficacy, and consistency of their biologic products.
Innovent Biologics focuses on several key therapeutic areas, including oncology, autoimmune diseases, and metabolic disorders. Their research and development efforts are aimed at addressing unmet medical needs in these areas by developing innovative biologic therapies.
Yes, Innovent Biologics has a dedicated regulatory affairs team that provides support for regulatory submissions. They assist clients in navigating the complex regulatory landscape, ensuring that all necessary documentation and data are prepared and submitted in compliance with local and international regulations.
Innovent Biologics Staff Directory
Search Innovent Biologics Staff Directory
Find accurate personal emails, work emails and phone numbers for employees
Supercharge your
Prospecting &
Outreach with
ContactOut
Supercharge your Prospecting &
Outreach with ContactOut
Find countless prospects outside of LinkedIn fast
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.
